Pete Ostergard currently serves as Managing Partner at Edgewater Capital Partners while contributing his leadership and industry insight as a member of REV Clinical’s Board of Directors. With decades in biotech and life sciences, Pete has held executive roles in corporate development, strategic operations, and investment leadership, supporting companies from startup through acquisition. He has guided deal strategy, fundraising, and growth planning across therapeutic and technology sectors. Pete holds a BA from Vanderbilt University.